ImmunityBio, Inc.（纳斯达克代码：IBRX）今日盘后股价大涨5.11%，引起了市场的广泛关注。
消息面上，公司宣布将于近期举行2025财年财务业绩发布会，届时管理层将详细介绍业务最新进展，并对全年财务数据进行全面解读。此次会议为投资者提供了深入了解公司战略布局与未来发展动向的重要窗口，市场对此反应积极。
ImmunityBio, Inc.（纳斯达克代码：IBRX）今日盘后股价大涨5.11%，引起了市场的广泛关注。
消息面上，公司宣布将于近期举行2025财年财务业绩发布会，届时管理层将详细介绍业务最新进展，并对全年财务数据进行全面解读。此次会议为投资者提供了深入了解公司战略布局与未来发展动向的重要窗口，市场对此反应积极。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.